MAP2K7 and cancer: Inhibition of the MTOR pathway phenocopied inhibition of the MEK-ERK or AKT pathways, suggesting that MTOR is a downstream effector of both the MEK-ERK and AKT pathways for actin reorganization in Rb-depleted hypoxic cancer cell lines.